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Introduction
Measurement is a fundamental component of evidence-
based medicine and provides the necessary information cli-
nicians require to make decisions in patient management. 
However, patients are increasingly active in their own treat-
ment; therefore, collecting biological, laboratory informa-
tion and mortality rates only is no longer adequate.1 Other 
outcomes such as health status, level of disability and qual-
ity of life are now common in the literature. It is commonly 
asserted that the patient’s perspective should inform in clin-
ical decision-making and direct collection of outcome data 
from the patient should be incorporated in clinical prac-
tice.1–6 Patient-reported outcome measures (PROMs) are 
‘standardised, validated questionnaires that are completed 
by patients to measure their perceptions of their own func-
tional status and wellbeing’.2 In the past two decades, many 
PROMs have been developed, and increasingly, their role 
in clinical practice has been emphasised.1,2,7,8 PROMs are 
considered to be the gold standard for outcome measure-
ment of subjective experiences, because the information 
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captured comes directly from the patient and well-validated 
tools reflect the concerns and main problems of the clinical 
population.1,9 In palliative care settings, systematic collec-
tion of patient-reported outcomes using validated question-
naires may benefit clinical practice both at the population 
and individual patient level. This may be achieved by the 
following mechanisms: (a) facilitating identification and 
screening of physical, psychological, spiritual and social 
unmet needs that might otherwise be overlooked; (b) pro-
viding information on disease progression and impact of 
treatment prescribed; (c) facilitating patient/family/carer–
clinician communication, promoting the model of patient-
centred care by shared decision-making and advanced care 
planning, establishing common priorities and expectations 
regarding outcomes of treatment and disease progression, 
which does not mean using a PROM to act as a substitute 
for the therapeutic relationship, but rather to complement 
it; and (d) monitoring outcomes by performing audits as a 
strategy for improvement of the quality of care provided 
and its costs.10,11 Finally, if funding health-care institutions 
were to be allocated depending on performance and out-
comes of the services, having those data available would be 
critical.
Models have been developed to fit health-related quality 
of life (HRQoL) and other PROMs data collection into clin-
ical practice.12 Building on Wilson and Cleary’s12 concep-
tual model of patient outcomes, Osoba developed a model 
for HRQoL assessment, describing how to incorporate 
HRQoL measures into clinical practice, throughout the dis-
ease trajectory. Outcome measures are used like a conven-
tional laboratory test, that is, to inform the differential 
diagnosis and monitor a patient’s progress. These types of 
data can be helpful in several phases of a condition or dis-
ease management: during the initial history and physical 
examination, laboratory and imaging procedures of investi-
gation leading to a diagnosis, all phases of treatment and 
follow-up.13 However, despite recommendations, the rou-
tine use of PROMs in palliative care clinical practice has 
been slow to implement, so their optimal role in assisting 
decision-making and improving quality of care is yet to be 
achieved.2,14
In other areas, for example, psychiatry, work has been 
developed on implementing PROMs in clinical practice 
where it has been suggested that to implement outcome 
measurement in a clinical unit and have clinicians conduct 
it as part of their clinical routine, takes at least 1 year.15 
Despite the evidence indicating that routine outcome 
assessment has benefits for mental health patients, there are 
a number of reasons as to why it has not been adopted in 
most services.16 These include lack of appropriate instru-
ments, time and incentives (financial and professional); 
lack of consensus regarding what outcome domains to 
include and what assessment measures to use; and clini-
cians remaining unconvinced of the benefits of routinely 
monitoring outcomes. Furthermore, barriers to successful 
screening for depression in cancer settings involve patient 
and clinician factors: acceptability of screening is critical to 
implementation, clinician confidence/skills influence 
screening success and training may improve confidence but 
effects upon long-term outcomes are modest.17 The latter 
seems to be a consequence of not providing clinicians with 
interpretation of scores, no mandating follow-up, not link-
ing screening with training or other types of clinician sup-
port, and screening being generally ineffective without 
aftercare.17
Two frameworks that have been developed are relevant 
for this review. One pertains to the implementation of clin-
ical practice guidelines that describes five steps: assess-
ment of clinician’s stage of readiness to change, assessment 
of specific barriers to guideline use, determination of 
appropriate level of intervention, design of dissemination 
and implementation strategies and evaluation of the strate-
gies implemented.18 The other, ‘Promoting Action on 
Research Implementation in Health Services’ (PARIHS) 
framework was developed to incorporate research into 
practice.19–21 It suggests that successful implementation is 
a function of the relation between the nature of the evi-
dence, the context in which the proposed change is to be 
implemented and the mechanisms by which the change is 
facilitated. It is advocated that (a) implementing research 
into practice is an organisational issue rather than an indi-
vidual one; (2) there is a need to carefully plan implemen-
tation strategies such as interventions that address the need 
for education, audit and the management of change and (c) 
criteria for evaluating the impact of the intervention must 
be identified and agreed upon before implementing any 
change. The role of the facilitator seems to be paramount 
as the facilitation is considered to be an intervention for 
getting research into practice. Finally, the facilitation pro-
cess is also emphasised in a study, which aimed at imple-
menting two end-of-life care tools in care homes.22 A 
model of high facilitation was used. This included an expe-
rienced palliative care nurse facilitating the project and 
visiting the sites multiple times and key champions attend-
ing a 4-day facilitative course and cascading this training 
down to their own staff.
Systematic reviews on the use of outcome measurement 
in clinical practice have focused on the impact and effec-
tiveness of PROMs in clinical practice but none of them 
covered the process of implementing the measures.23–25 
There is a brief review exploring assessment of only quality 
of life in one particular setting, that is, oncology practice.26 
Understanding the facilitators and barriers to the imple-
mentation of PROMs in palliative care settings could 
potentially inform the process of their implementation. 
Therefore, this review aimed to systematically identify 
facilitators and barriers to the implementation process of 
routine use of PROMs in different palliative care settings 
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and generate evidence-based recommendations, to inform 
the implementation process in clinical practice. The objec-
tives of this review were to (a) identify barriers and facilita-
tors to the systematic implementation of PROMs in 
palliative care clinical practice, (b) identify needs and other 
comments of clinical teams regarding the routine use of 
PROMs and (c) identify lessons learned on the process of 
implementation of PROMs in clinical practice.
Methods
Design
This systematic review follows the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
recommendations.27
Study identification
Studies were identified using a systematic search of elec-
tronic databases with additional hand-searching of refer-
ence lists of included articles.27
Search strategy
Five databases (Medline, PsycInfo, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), Embase 
and British Nursing Index (BNI)) were searched and 
included the literature published between 1985 and August 
2011. It was decided to exclude all the literature before 
1985 because PROMs only start to emerge in the literature 
in the late 1980s. The searches were conducted between 29 
August 2011 and 2 September 2011. The search was 
updated on 19 March 2012. Using Medical Subject 
Heading (MeSH) terms and free text, keyword groups, 
including ‘palliative care’, ‘PROMs’, ‘clinical practice’ 
and ‘facilitators and barriers’, were combined in several 
ways. Slight changes were made according to each data-
base. Appendix 1 has the full search strategy for BNI. Data 
search was supplemented by hand search of reviews and 
relevant articles.
Study selection
Inclusion criteria are as follows: (a) primary studies 
reported in English, Portuguese, Spanish, Italian, German 
and French because these languages were spoken in the 
wider study team; (b) studies using a PROM alongside the 
clinical care of adult patients (18 years old or older) with 
advanced disease in palliative care settings; and (c) studies 
reporting barriers and/or facilitators of the implementation 
of the PROM. Articles had to meet all the inclusion criteria, 
and no exclusion criteria to be included. All study designs 
were included.
Exclusion criteria are as follows: (a) published literature 
other than primary studies (i.e. review articles, books and 
conference articles); (b) studies reporting exclusively on 
development and feasibility phases of new measures, which 
did not include comments of users; and (c) studies of 
PROMs completed by proxies.
Selection procedure
All titles and abstracts were reviewed by one reviewer 
(B.A.) to assess eligibility for inclusion in the review. Full 
texts were retrieved if the inclusion criteria were met or the 
abstract contained insufficient information. Any uncer-
tainty about eligibility after assessing full text was assessed 
by a second reviewer (I.J.H.).
Data extraction
Data were extracted by one reviewer (B.A.) and assessed 
by a second reviewer (N.C.). Tabulation was used as a first 
step. The author, country, aim, population, study design, 
measures used, settings, facilitators and barriers were 
extracted. Clauses were taken and kept as reported.
Analysis
Incorporating qualitative data into systematic reviews has 
been recognised as an important contribution for providing 
and analysing non-numerical research data by answering 
questions that are not easily addressed exclusively by 
experimental methods.28,29 Hence, a narrative synthesis 
was conducted following a framework of four elements to 
ensure robustness of the findings as described in the 
Guidance on the Conduct of Narrative Synthesis in 
Systematic reviews.30 Element 1 concerns the role of the-
ory in evidence synthesis, Element 2 refers to the develop-
ment of a preliminary synthesis, Element 3 pertains to 
exploring relationships within and between studies and in 
Element 4, the robustness of the synthesis is assessed. This 
method has proved to be useful in synthesising different 
types of data from different study designs.31 There is more 
than one technique to choose from in order to conduct 
Elements 2–4, depending on the data extracted, and the 
following were the chosen techniques for each element in 
this review:
Element 1: the role of theory in evidence synthesis. We 
present a theory as suggested in the guidance, which 
will contribute to the interpretation of the findings and 
the assessment of how widely applicable the findings 
might be.
Element 2: developing a preliminary synthesis. Element 
2 was achieved by (a) grouping the data by tabulation 
and (b) performing thematic analysis. This allowed for 
the systematic identification of the main themes.
Element 3: exploring relationships within and between 
studies. Element 3 was achieved by (a) exploring the 
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influence of heterogeneity by focusing attention on the 
characteristics of the different studies and their potential 
relationships to the findings, (b) reciprocal translation 
by identifying common concepts across studies and (c) 
conceptual mapping was performed linking multiple 
pieces of evidence extracted from the different studies 
representing the relationships between them. Categories 
were first developed for each main theme. Data were 
then organised in a timeline, by implementation steps 
and sequenced actions. Any discrepancies were resolved 
by discussion (B.A. and N.C.).
Element 4: assessing robustness of the synthesis. There 
are two steps to carry out described in the guidance, 
as follows: (a) assessing the methodological quality of 
included studies and (b) being rigorous in the meth-
odology used to synthesise findings and being critical 
regarding limitations of methods used. The latter will 
be included in the ’Strengths and limitations’ section 
given under the ‘Discussion’ section. There are no 
universally accepted guidelines for either assessing the 
quality of specific qualitative methods nor an accepted 
set of criteria to assess the quality of qualitative and 
quantitative studies in order to incorporate their find-
ings in a systematic review.28–30,32–36 We used the modi-
fied Harden criteria to assess the methodological qual-
ity of the included studies (Table 1).37,38 Two reviewers 
(B.A. and V.S.) assessed the quality of the studies inde-
pendently. Discrepancies were resolved by discussion. 
Studies with a qualitative design were assessed accord-
ing to 16 criteria subdivided into two dimensions: clar-
ity of reporting and robustness of the study methods. 
The first dimension refers to a clear description of con-
text, study aims, research question, choice of specific 
study design, sampling, data collection, analysis and 
findings and has a maximum score of 8. The second 
refers to a comprehensive sampling strategy, reliabil-
ity and validity of the data collection and analysis. It 
roots the findings in the perspectives and experiences 
Table 1. Quality assessment instruments for qualitative and quantitative studies.
Qualitative Quantitative
Clarity of reporting
 1. Was the context of the study clearly described?a X X
 2. Were the goals of the study clearly described? X X
 3. Was the research question clearly defined? X X
 4. Was the design adequate for the study goal/question? X X
 5a. Was the identification and the recruitment of the sample clearly described and justified? X  
  5b. Was there an adequate description of the study population (setting, selection 
criteria and age/gender)?
X
 6. Were the data collection methods clearly described? X X
 7. Were the data analysis methods clearly described? X X
 8. Were the findings clearly described? X X
Robustness of the study methods
  9a. Was the sampling strategy comprehensive to ensure the generalisability of the 
results?
X  
  9b. Was the size of the study population sufficient to ensure the generalisability of 
the results?
X
 9c. Was the response rate sufficient to ensure the generalisability of the results? X
 10a. Were methods used to establish the reliability of the data collection methods? X  
 10b. Were reliable measurement instruments used? X
 11a. Were methods used to establish the validity of data collection? X  
 11b. Were valid measurement instruments used? X
 12a. Were methods used to establish the reliability of the data analysis? X  
 13a. Were methods used to establish the validity of the data analysis? X  
 12b and 13b. Were adequate analysis techniques used? X
  14. Did the research move logically from a description of the data, through 
quotations or examples, to an analysis and interpretation of the meanings and their 
significance?
X  
  15. Was evidence of reflexivity in the process reported (interim data analyses guides 
further data collection and analyses)?
X  
 16. Were the findings really rooted in the perspectives of the population studied? X  
Number of positive criteria 16 13
The original 10 criteria from Harden are printed in italic format.
aModified Harden criteria in Slort et al.37,38
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of the respondents, logically proceeding from data to 
interpretation and reflexivity, which has a maximum 
score of 8. Regarding the studies with a quantitative 
design, 13 criteria were used, also subdivided in those 
two dimensions. The maximum possible score for ro-
bustness of study methods was 5. If the study used a 
mixed-methods approach, then the methodology that 
provided the data of interest for this review, was rated. 
Each criterion was rated as ‘yes’ or ‘no’, and if there 
was insufficient information, the score was ‘no’. Stud-
ies were rated by both reviewers as ‘high’, ‘medium’ 
or ‘poor’ quality. However, no studies were excluded 
based on the quality score because there is no consen-
sus on the minimum quality assessment score required 
for inclusion in a review.29
Results
Identification and inclusion of studies
The search strategy yielded a total of 3863 hits. Following 
screening of titles and abstracts (Figure 1), 421 articles 
were reviewed in full detail and 393 were excluded for not 
having comments on PROMs use, implementation of the 
measure(s), nor use in clinical practice. Twenty-six studies 
were included within 31 articles.
Eleven studies were conducted in the United Kingdom, 
seven in the United States, two in the Netherlands and one 
in each of the following countries: Australia, Canada, 
Israel, Italy, Malaysia and Vietnam (Table 2). There were 
no intervention studies testing the introduction of facilita-
tors to overcome barriers when implementing PROMs in 
clinical practice. Eight studies used qualitative methods 
and provided structured, in-depth information about the 
facilitators, barriers and lessons learned when implement-
ing PROMs in palliative care clinical practice. These stud-
ies used a range of designs (n = 4) including web-based 
online surveys, semi-structured interviews with patients 
and clinicians either face to face or by phone and meetings 
with clinical teams and focus groups. Seventeen studies 
used quantitative methods (n = 7) and none looked at facil-
itators or barriers to the implementation of PROMs as a 
primary outcome. One randomised controlled trial evalu-
ated the efficacy of standardised HRQoL assessments used 
in facilitating patient–physician communication. The 
PROMs used in the studies include seven measures on pain, 
seven on symptoms, eight on quality of life and six measur-
ing other concepts (Table 2).
Narrative synthesis framework
Element 1: the role of theory in evidence synthesis. We draw 
on work conducted in other fields, including an adaptation 
of the Slade70 model, and on the early social and behav-
ioural psychology theories, which are the base for organisa-
tional theories of change.15,18 The model (Figure 2) takes 
into consideration that implementation is an ongoing 
dynamic process, and that staff from any setting with par-
ticular characteristics and rules are individuals with ongo-
ing cognitive and emotional processes. These influence 
how they relate and work with colleagues, patients and 
families and how they react to change.
Element 2: developing a preliminary synthesis. Tabulation 
allowed us to find, at an early stage of the analysis, that 
there were no intervention studies of implementing facili-
tators to overcome barriers when using a PROM in pallia-
tive care clinical practice. This was an important finding, 
which allowed for the integration and analysis of the data 
in a way that was most informative but still answered our 
question. Then, thematic analysis was performed. We first 
applied our a priori three main themes: facilitators, barri-
ers and lessons learned (see Appendix 2 for all data 
extracted). Most data extracted from the included studies 
were in the form of narrative observations located in the 
‘Discussion’ and ‘Conclusion’ sections. In-depth data 
explicitly reported in the ‘Results’ section were also 
extracted, mainly from the focus groups studies and the 
web-based online survey study.
Element 3: exploring relationships within and between stud-
ies. After integrating the data in the main themes, in-depth 
inductive analysis led to the creation of five different cate-
gories for facilitators and lessons learned and six categories 
for barriers, namely, management, education, tool specific, 
clinical utility, financing and attitudes. All categories are 
presented in Table 3 accompanied by an illustrative quote 
per category.
In addition, as analysis continued, a different typology 
emerged. This led us to reorganise the data in a timeline. We 
suggest three sequential steps at different levels (see 
Appendix 3 for detailed data): (a) preparation, with different 
actions put in place simultaneously at management level, 
health-care professional level and patient level; (b) imple-
mentation, in which the measure is taken into clinical prac-
tice, and different tasks are fulfilled at different levels and 
(c) assessment and improvement, which begins with the 
implementation step and involves discussion and potential 
changes of actions previously implemented. Hence, data 
were organised by those three sequential steps including 
barriers, facilitators and lessons learned for each. 
Similarities between studies emerged as some facilitators, 
barriers and lessons learned appear to be common to all 
sequential steps. Furthermore, by categorising the data as 
described (Figure 3), it seemed that some barriers discussed 
in some studies were being answered/resolved by facilita-
tors and lessons learned mentioned in other studies. By 
exploring these relationships, we were able to link different 
concepts and synthesise them in the form of recommenda-
tions for implementing PROMs in palliative care clinical 
practice (Table 4).
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Element 4: assessing the robustness of the synthesis. We 
applied our quality criteria and categorised six qualitative 
studies as high quality because these scored 13 or more, 
two as medium quality having scored between 10 and 12 
and one as poor quality since it scored below 10. Regarding 
the quantitative studies, 10 were rated high quality for scor-
ing 11 or higher, and a score of 10 was rated as medium 
quality; however, there were no studies with this score, and 
CINAHL
553
Embase
668
Medline
1136
BNI
732
PsycInfo
774
3863
Aer checking for duplicates: 3536
referencesExcluded/Irrelevant based on tle and
abstracts 
Language –38
Not advanced disease – 1256
No use of PROMs – 1570
Conferences – 38
Book – 111
Paediatrics – 121
Total: 3134
Included for further invesgaon: 
402
Addional 19 references aer 
manual searches of the reference 
lists and review arcles: 421
Total number of included studies: 26
Total number of arcles: 31
Excluded/Irrelevant aer screening 
full text (no comments on PROMs 
use nor implementaon and use in 
clinical pracce): 393
Search update: 19th March 2012: 253
Included: 2
Figure 1. Flow chart based on PRISMA recommendations reporting the literature search and selection of articles.
CINAHL: Cumulative Index to Nursing and Allied Health Literature; BNI: British Nursing Index; PROM: patient-reported outcome measure; PRISMA: 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
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Table 2. Characteristics, measures used and quality assessment of included studies (N = 31).
Reference, 
country
Aim Study design, 
population and 
setting
Type of data 
reported
Measures Clarity of 
reporting
Robustness 
of the study 
methods
Quality 
assessment 
sum score
Bouvette  
et al.,39 
Canada
To determine the feasibility of 
implementing the PSAR in a 
variety of settings
Qualitative 
exploratory: focus 
groups with nurses; 
chart audits
Palliative care 
institutions in Ottawa
In-depth data 
explicitly reported in 
results
Facilitators and 
barriers extracted
PSAR 8/8 7/8 15/16
 
Bourbonnais 
et al.,40 
Canada
 
To focus on the importance 
of the use of tools for pain 
and symptom management, 
issues around implementing 
them and sustaining their use 
in the clinical setting
Article reporting 
lessons learned 
from conducting the 
earlier study
Narrative opinions 
related to the earlier 
study
Facilitators, barriers 
and lessons learned 
extracted
– – – –
 
Dunckley  
et al.,41 UK
 
 
To identify facilitators and 
barriers to implementing 
outcome measures and to 
identify and facilitate methods 
of overcoming those barriers
Qualitative: action-
research approach. 
Semi-structured 
interviews with 
clinicians; diary 
completion; monthly 
meetings
Hospice
In-depth data 
explicitly reported in 
results
Mainly facilitators 
extracted
POS 8/8 7/8 15/16
 
 
Bausewein  
et al.,42 UK
 
 
To describe the use and 
experiences with PROMs 
of professionals working in 
palliative care in Europe and 
Africa
Qualitative: web-
based online survey 
to clinicians
Multiple settings, 
both in Europe and 
in Africa
In-depth data 
explicitly reported in 
results
Mainly barriers 
extracted
N/A 8/8 7/8 14/16
 
 
Daveson 
et al.,43 UK
 
 
To examine and compare 
doctors’ and nurses’ views 
and experiences regarding 
outcome measurement in 
palliative care, including 
PROMs
Qualitative: web-
based online survey 
to clinicians
Multiple settings, 
both in Europe and 
in Africa
In-depth data 
explicitly reported in 
results
Mainly barriers 
extracted
N/A – – –
 
 
Harding 
et al.,44 UK
 
 
To identify the outcome tools 
currently in use in end-of-
life care (both clinically and 
for research) across Europe 
and investigate the preferred 
features of outcomes tools 
from the perspective of those 
who select and apply them
Qualitative: web-
based online survey 
to clinicians
Multiple settings, 
both in Europe and 
in Africa
In-depth data 
explicitly reported in 
results
Mainly barriers 
extracted
N/A – – –
 
 
Schulman-
Green 
et al.,45 USA
 
 
To develop and pilot test 
performance measures and 
a data collection system 
that hospices could use in 
partial fulfilment of CMS 
requirements
Qualitative: semi-
structured telephone 
interviews
Hospice staff
In-depth data 
explicitly reported in 
results
Mainly lessons 
learned extracted
ESAS 7/8 7/8 14/16
 
 
Schwartz 
et al.,46 USA
 
To evaluate the feasibility 
and utility of the MVQOLI-R 
during over 6 weeks of use; 
explore the utility of the 
MVQOLI-R as a research 
and/or clinical tool (i.e. 
a psychometric versus 
clinimetric instrument)
Qualitative: semi-
structured interviews 
to clinicians
Hospice, home and 
Pall Care settings
In-depth data 
explicitly reported in 
results
Mainly lessons 
learned extracted
MVQOLI-R, 
MSAS
8/8 6/8 14/16
 
Hughes 
et al.,47 UK
 
 
To describe the 
implementation of a palliative 
care outcome measure in 
non-specialist palliative care 
settings and to understand 
the implementation of the 
measure
Qualitative: semi-
structured interviews 
to staff and patients
15 non-specialist 
palliative care 
settings
In-depth data 
explicitly reported in 
results
Mainly barriers and 
lessons learned 
extracted
POS 7/8 6/8 13/16
 
 
(Continued)
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Reference, 
country
Aim Study design, 
population and 
setting
Type of data 
reported
Measures Clarity of 
reporting
Robustness 
of the study 
methods
Quality 
assessment 
sum score
Cox et al.,48 
UK
 
 
To focus on the clinical 
acceptability of a 
computerised assessment 
tool and present the 
difficulties in evaluating the 
support the tool provided to 
patients
Qualitative: semi-
structured interviews 
by telephone or in 
person to clinicians 
and patients
Hospice
In-depth data 
explicitly reported in 
results
Mainly barriers 
extracted
ESAS, EQ-
5D
7/8 4/8 11/16
 
 
Hughes 
et al.,49 UK
 
This study investigated 
professionals’ views of using 
outcome measures with 
special reference to one, the 
POS
Qualitative: semi-
structured telephone 
interviews to health-
care professionals
In-depth data 
explicitly reported in 
results
Mainly barriers and 
lessons learned 
extracted
POS 6/8 4/8 10/16
 
Hughes 
et al.,50 UK
 
Assessing palliative care 
outcomes for people with 
MND living at home
Qualitative: semi-
structured interviews 
to MND patients
In-depth data 
explicitly reported in 
results
Mainly facilitators and 
barriers extracted
– – – –
 
Barret,51 UK
 
To develop an assessment 
tool in wound care that can 
be used by the practitioner
Qualitative: meeting 
with district nursing 
team
Narrative opinions
Mainly lessons 
learned extracted
Pain 
monitoring 
Aid
4/8 4/8 8/16
 
Eagar et al.,52 
Australia
 
 
Establishing a national system 
(the PCOC) to measure 
outcomes and quality of 
specialist palliative care 
services and to benchmark 
services across the country
National system to 
measure outcomes 
in palliative care 
services
111 palliative care 
settings
Narrative opinions
Mainly lessons 
learned extracted
PCOC 
tool kit 
(Palliative 
Care 
Phase, SAS, 
RUG-ADL, 
Australian-
modified 
KPS, PCPSS 
and some 
items of the 
POS)
8/8 5/5 13/13
 
 
Rawlings 
et al.,53 
Australia
 
Using PACA tools to 
influence and enhance clinical 
practice
National system to 
measure outcomes 
in Palliative care 
services
Narrative opinions 
related to the earlier 
study
Mainly lessons 
learned extracted
– – – –
 
Detmar 
et al.,54 the 
Netherlands
 
 
To evaluate the efficacy 
of standardised HRQoL 
assessments in facilitating 
patient–physician 
communication and increasing 
physicians’ awareness of their 
patients’ HRQoL-related 
problems
Quantitative: 
prospective, 
randomised 
crossover trial
Outpatient clinic of a 
cancer hospital
Narrative opinions
Mainly lessons 
learned extracted
EORTC 
QLQ-C30, 
COOP, 
WONCA, 
SF-36, 
ECOGS, 
PSQ C
8/8 5/5 13/13
 
 
Caraceni 
et al.,55 Italy
 
 
 
To assess the compliance of 
hospitalised patients with 
chronic cancer pain, referred 
to an inpatient palliative care 
consultation service, with self 
assessment of pain intensity 
by means of a daily pain form
Quantitative: 
prospective 
longitudinal
Hospitalised patients
Tertiary oncological 
referral centre
Narrative opinions
Facilitators, barriers 
and lessons learned 
extracted
0-10 NRS 7/8 5/5 12/13
 
 
 
Ellershaw 
et al.,56 UK
 
 
To evaluate the effectiveness 
of a hospital palliative care 
team in the provision of 
symptom control, patients’ 
and relatives’ awareness of 
the diagnosis and outcome 
regarding the patients’ 
placements
Quantitative: 
prospective 
longitudinal study
Cancer patients 
referred to a 
hospital-based 
palliative care team
Narrative opinions PACA tool 8/8 4/5 12/13
Mainly lessons 
learned extracted
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Reference, 
country
Aim Study design, 
population and 
setting
Type of data 
reported
Measures Clarity of 
reporting
Robustness 
of the study 
methods
Quality 
assessment 
sum score
Escalante 
et al.,57 USA
 
 
To separately profile fatigue 
in cancer patients with solid 
tumours or haematological 
malignancies who were being 
served in the EC
Quantitative: 
retrospective chart 
review
Emergency centre
Narrative opinions
Mainly lessons 
learned extracted
NRS for 
fatigue and 
pain
7/8 5/5 12/13
 
 
Ewing 
et al.,58 UK
 
 
To investigate the agreement 
on symptom assessments 
between patients at home and 
GPs and district nurses
Quantitative: cross-
sectional prospective 
study
Adult palliative care 
patients estimated to 
be in their last year 
of life
Narrative opinions
Mainly lessons 
learned extracted
CAMPAS-R 
(VAS), 
CAMPAS-P 
(VAS)
8/8 4/5 12/13
 
 
Hoekstra 
et al.,59 the 
Netherlands
 
To achieve symptom relief 
through systematic and 
regular symptom reporting by 
patients themselves
Quantitative: RCT
Hospital and GP 
practice
Narrative opinions
Mainly barriers and 
lessons learned 
extracted
Symptom 
monitor
8/8 4/5 12/13
 
Kamel 
et al.,60 USA
 
 
To investigate the effect of 
utilising a combination of 
three easily administered pain 
assessment instruments on 
the frequency of diagnosing 
pain among elderly nursing 
home residents
Quantitative: 
cross-sectional pain 
assessment + chart 
review
Nursing homes
Narrative opinions
Mainly lessons 
learned extracted
VAS for 
pain, pain 
descriptive 
scale and 
behaviour 
scale
7/8 5/5 12/13
 
 
De Rond 
et al.,61 the 
Netherlands
 
 
To assess the feasibility 
of daily pain assessment 
from nurses’ and patients’ 
perspective in multiple 
settings
Quantitative: 
feasibility study
2 general hospitals 
and 1 university 
hospital. In each, 
2 surgical and 1 
medical wards
In-depth data 
explicitly reported in 
results
Mainly lessons 
learned extracted
NRS 7/8 4/5 11/13
 
 
Jette et al.,62 
USA
 
 
To determine (a) the extent 
of the use of standardised 
outcome measures and (b) 
perceptions regarding their 
benefits and barriers to their 
use
Quantitative: 
observational. Paper 
survey
Physical therapists
In-depth data 
explicitly reported in 
results
Mainly barriers and 
lessons learned 
extracted
N/A 8/8 3/5 11/13
 
 
Defilippi and 
Cameron,63 
UK
 
 
To assess the impact of 
a model of introducing a 
palliative care component and 
professional supervision of 
community caregivers on the 
quality of care given to people 
living with HIV/AIDS and their 
families
Quantitative: 
prospective 
longitudinal pilot 
study
Hospice based but 
home care program
Narrative opinions
Mainly barriers and 
lessons learned 
extracted
APCA POS 5/8 4/5 9/13
 
 
Hardy 
et al.,64 UK
 
 
To determine whether a QoL 
instrument could be used 
as a primary end point or 
outcome measure in palliative 
care
Quantitative: 
prospective 
longitudinal study
Palliative care unit
Narrative opinions
Mainly barriers and 
lessons learned 
extracted
RSCL 5/8 4/5 9/13
 
 
Bercovitch 
et al.,65 Israel
 
 
To present preliminary 
experience with the MCPAC
Quantitative: 
prospective 
longitudinal
Hospice terminal 
cancer patients
Narrative opinions
Mainly barriers and 
lessons learned 
extracted
MCPAC 5/8 4/5 9/13
 
 
Chang 
et al.,66 USA
 
 
To evaluate the acceptability 
of the computer-
administrated program to 
patients and the most useful 
and appropriate presentation 
of patients’ QoL information 
to treating oncologists
Quantitative: 
feasibility study, 
prospective 
longitudinal
Oncology clinic
Narrative opinions
Mainly barriers and 
lessons learned 
extracted
Electronic 
FACT-L
6/8 2/5 8/13
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Table 2. (Continued)
Antunes et al. 167
Reference, 
country
Aim Study design, 
population and 
setting
Type of data 
reported
Measures Clarity of 
reporting
Robustness 
of the study 
methods
Quality 
assessment 
sum score
Clark et al.,67 
USA
 
 
To describe the 
implementation of the 
touch screen technology 
as an effective psychosocial 
screening tool with immediate 
clinical utility
Quantitative: 
prospective 
longitudinal study
Cancer centre
In-depth data 
explicitly reported in 
results
Mainly facilitators 
extracted
‘How can 
we help 
you and 
your family’ 
screening 
instrument
6/8 2/5 8/13
 
 
Devi and 
Tang,68 
Malaysia
 
 
To study the feasibility of 
modifying the use of a pain 
assessment tool
Quantitative: 
feasibility study
Hospital, oncology 
ward
Narrative opinions
Mainly facilitators 
extracted
Short form 
of the 
Brief Pain 
Inventory, 
Wong-
Baker 
FACES 
Scale
5/8 35/ 8/13
 
 
Green 
et al.,69 
Vietnam
 
 
To evaluate the impact of 
integrating palliative care 
services within a district HIV 
outpatient ART clinic setting 
by assessing changes in pain, 
other symptoms, depression, 
anxiety and perceived social 
support, and exploring 
intervention accessibility, 
acceptability and feasibility
Quantitative: 
non-randomised 
controlled trial
HIV outpatient clinics
Narrative opinions
Mainly lessons 
learned extracted
10 point 
symptom 
severity 
scales
5/8 2/5 7/13
 
 
PROM: patient-reported outcome measure; CMS: Centers for Medicare and Medicaid Services; PCOC: Palliative Care Outcomes Collaboration; MND: motor neurone 
disease; HRQoL: health-related quality of life; GP: general practitioner; RCT: randomised controlled trial; QoL: quality of life; ART: antiretroviral treatment; PSAR: The 
Ottawa pain and symptom assessment record; POS: Palliative care Outcome Scale; N/A: not applicable; ESAS: Edmonton Symptom Assessment Scale; MVQOLI-R: Missoula-
VITAS Quality of Life Index–Revised; MSAS: Memorial Symptom Assessment Scale; EQ-5D: European Quality of Life-5 Dimensions; SAS: symptom assessment scale; 
RUG-ADL: Resource Utilization Group/Activities of Daily Living; KPS: Karnofsky Performance Score; PCPSS: Palliative Care Problem Severity Score; EORTC QLQ-C30: 
European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire Core 30; COOP: Dartmouth Primary Care Cooperative Information 
Functional Health Assessment; WONCA: World Organization Project of National Colleagues and Academics; SF-36: Medical Outcomes Study 36-Item Short-Form Health 
Survey; ECOGS: Eastern Cooperative Oncology Group scale; PSQ C: Patient Satisfaction Questionnaire C; NRS: numeric rating scale; PACA: Palliative Care Assessment; 
CAMPAS-R: comprehensive measure for palliative care for patients; VAS: visual analogue scale; CAMPAS-P: comprehensive measure for palliative care for professionals; 
APCA POS: African Palliative Care Association African Palliative care Outcome Scale; RSCL: Rotterdam symptom checklist; MCPAC: multidimensional continuous pain 
assessment chart; FACT-L: Functional Assessment of Cancer Therapy-Lung; EC: Emergency Centre. 
Articles ordered by quality assessment sum score. Articles, which do not present scores, describe the same study as the article immediately above.
Table 2. (Continued)
seven studies scored 9 or below and so were rated as poor 
quality (Table 2).
Discussion
To our knowledge, this is the first systematic review that 
specifically identifies and appraises facilitators and barri-
ers and draws recommendations of implementation of 
PROMs in clinical practice in palliative care. Although 
there were no intervention studies identified in this review, 
the qualitative data provided structured, in-depth informa-
tion about the facilitators, barriers, needs and lessons 
learned when implementing PROMs in palliative care 
clinical practice. The quantitative studies identified did 
not meet our inclusion criteria as primary aims but pro-
vided useful data as secondary outcomes or process data 
from the original studies.
Our main findings are in line with our initial theory 
based on work conducted in other fields. First, during the 
implementation process, there is the need to acknowledge 
interpersonal relationships between the clinical team 
members and the ongoing emotional and cognitive pro-
cesses that occur in each individual. Fear of change, feel-
ing that one is being assessed and that one’s work is open 
to criticism due to the results that PROMs might show, 
and fear of added work are a few of the concerns that may 
lead to behaviour, which opposes change. Therefore, a 
firm but sensitive leadership seems to be needed to moti-
vate individuals and reassure them that the use of PROMs 
is beneficial and ultimately aims to improve the quality 
of care provided to patients (Appendix 2, management 
category). Allowing individuals to take ownership of the 
measures rather than mandating their use may be impor-
tant to avoid conflict. Providing feedback to clinicians 
appears to be a powerful tool to influence beliefs and atti-
tudes towards the use of PROMs in clinical practice 
(Appendix 2, clinical utility). Some authors have used 
organisational theories as a backdrop to inform and 
design indicators to measure the quality of delivery of 
health care in general practice.71
168 Palliative Medicine 28(2)
Paent assessment  >>  Paent outcomes  <<  Staff assessment
Staff receive informaon
Staff read informaon
Staff reflect on process and content of care
Staff awareness and behaviour change
Process of care is changed         Care plan discussed and changed
Improved collaboraon     New care provided
Improved outcomes – fewer unmet palliave needs and beer QoL
Staff is recepve to change, has agreed with roune assessment using outcome 
measures and has undergone training
A clinical se ng is a dynamic system with its own rules, ranks, values and beliefs. It is formed by individuals that may or 
may not share those values and beliefs and hence may be a driving force or an opposite force to change.17,18,20 Each 
individual has ongoing cognive and emoonal processes. The transtheorecal model of change, considers behaviour to 
be a connuous process made up of five stages: pre-contemplaon, contemplaon, preparaon, acon and maintenance. 
Moving from the 1st to the 2nd implies changing knowledge and a tudes, going from the 2nd to the 3rd and 4th stages
involves changes in emoonal processes such as posive beliefs about self efficacy and having or developing
the necessary skills and finally, evolving to the final stage implies restructuring the environment or
system in which the behaviour occurs and providing support.
Decisions to be made prior to implementaon of a PROM:
- Selecon of outcomes of interest
- Selecon of outcome measure(s)
- Educaonal component about measure and how to use results
- Selecon of one coordinator/facilitator
- Who applies the measure and its periodicity 
Discussion of benefits for paents 
and staff and potenal changes of 
process aiming at improving results
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Figure 2. Model describing implementation steps and the presence of facilitators and barriers throughout the process.
QoL: quality of life; PROM: patient-reported outcome measure.
Adapted from Slade.70
Second, implementing a PROM in palliative care clini-
cal practice appears to benefit from careful planning of 
three distinct phases or steps (Appendix 3). The preparation 
phase involves (a) ensuring all health-care professionals are 
comfortable with changes planned and having a coordina-
tor who will be in charge, (b) an education component and 
(c) selection of the measure(s) to be used. The latter is 
becoming more complex due to the high number of existing 
measures, many used only in research and/or just used in 
one study. This may not provide enough information about 
the measure in terms of using it in practice. Hence, the edu-
cational component seems to be key because if met, it will 
allow for clinicians to (a) understand why a measure is 
needed and how it could potentially benefit their practice; 
(b) learn about the measure(s), which will be implemented, 
namely, measurement properties, design and scoring 
system(s); (c) provide role play on how to explain PROMs 
usage to patients; (d) explore interpretation of results at 
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different levels to benefit not only the individual patient but 
also the population, which the setting serves; (e) discuss the 
best options for storing and managing the collected data; 
and (f) understand the evaluation, which will follow. This 
seems to be the most time-consuming step. During the 
actual implementation, the results of each assessment point 
(previously decided, for example, daily, weekly, at each 
appointment) provide feedback on monitoring the patient’s 
progress and disease management. Having timely feedback 
on patient outcomes aids clinical decision-making and may 
enhance communication not only between patient and clini-
cian but also within the multidisciplinary team. Finally, 
acknowledging what could be changed throughout the pro-
cess is important in order to make the necessary enhance-
ments with the overall aim of improving practice and the 
quality of care.
Implications for research
There are potential implications for future research that can 
be drawn from the findings, namely, whether the introduc-
tion of the measure(s) is an intervention in itself, regardless 
of the primary outcome of the study. Perhaps, there is an 
adjustment phase that needs to be taken into account before 
the actual main data collection takes place. It might be 
important to consider whether study protocols should 
include this period. There may be an impact on timing, that 
is, will the baseline be measured immediately after imple-
menting the use of the PROM(s) or will there be a period of 
adjustment for the users to become more familiar with the 
measure(s). The same could be said about analysis: thought 
must be put into whether or not to include the data collected 
in that period of time in the analysis, considering that 
Table 3. Categories of extracted facilitators, barriers and lessons learned.
Quotes
Facilitators – 5 categories
 (a) Management/organisational/setting specific ‘Prior meeting to explore feasibility of implementation of the 
measure: to implement measure, planning and evaluating are essential; 
coordinator is identified to undertake overall responsibility for 
implementation’41
 (b) Education (of all actors involved/training) ‘Educational program prior to implementation of the measure: – the 
importance of training in all aspects of use to help staff to become 
familiar and more comfortable with administering the tool’51
 (c) Tool specific ‘Burden of measure completion on patient/residents is considered’51
 (d) Clinical utility and relevance of a PROM ‘Measure asks about issues that are relevant to clinical care’51
 (e) Psychosocial theories/psychology of work ‘Persistence and encouragement by both the research assistant and 
the unit head nurse on the wards were necessary to ensure the 
implementation was successful’61
Barriers – 6 categories
 (a) Management/time ‘Not enough staff: time constraints and fear of added work’42
 (b) Education ‘Lack of training and guidance about how to use tools’42
 (c) Tool specific ‘Tools are too burdensome for patients & families and staff ’42
 (d) Financing ‘Cost constraints (e.g. fees for tools)’42
 (e) Illness specific ‘Overall severity of the disease condition’55
 (f)  Motivation/personality/attitudes/beliefs ‘Fear of change’67
Lessons learned – 5 categories
 (a) Management/setting level ‘Integrating a new routine into daily clinical practice takes time and 
effort’61
 (b) Education specific ‘Education regarding the tool will be tailored to suit the individual 
locality needs. This is to allow the staff to take ownership and 
understand the benefits to its use’51
 (c) Tool specific ‘Whatever scale is chosen, administration must follow specific 
guidelines, and administration modalities must be appropriate to the 
clinical or research needs and practical enough to obtain adequate 
patient compliance’55
 (d) Individual patient level ‘Reporting symptoms on a regular basis by patients was valuable 
because of the patients’ apparent awareness of their own 
symptoms’59
 (e) Carer level ‘Caregivers reported increased confidence in caring for people with 
advanced disease’63
PROM: patient-reported outcome measure.
One quote is provided as an example for each category.
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misuse of the measure(s) may have an impact on the 
strength and validity of results.
Strengths and limitations
One strength of this review is the heterogeneity of the 
included studies. These come from a large number of 
different countries as well as from different settings, which 
suggests that issues related with implementing PROMs are 
common and universal to clinical practice in palliative care. 
Furthermore, the fact that different measures were used in 
the included studies helps to clarify that challenges in 
implementing PROMs are not exclusive to the characteris-
tics of the chosen measure, but actually depend on an 
After data extraction and   
integration in a priori   Facilitators (F)       Barriers (B)          Lessons learned (LL)
themes
(Elements 2 and 3)                             Inductive in-depth analysis: development of categories
                                                                                       
     -Management   - Management               - Management  
Appendix 2         - Education   - Education               - Education
          - Tool specific   - Tool specific               - Tool specific    
          - Clinical utility PROM  - Financing               - Individual patient
          - Working relationships    - Illness specific               - Individual carer
       - Personality
Reorganisation of
data in a time-line
(Element 3)
   Preparation
           - Management - F  Clinical Team - F  Patient - B 
           - B         - B
           - LL         - LL
    Implementation
Appendix 3        - Management - F Clinical Team - F  Patient – F
                  - B        - B
                  - LL        - LL
     Assessment
          - Management - LL Clinical Team - F Patient – LL   
              - LL
   Common to all 3 steps:
    - Management - F    Clinical Team - B  Patient – B
            - B          - LL
            - LL
Table 4 RECOMMENDATIONS FOR IMPLEMENTING PROMs IN PALLIATIVE CARE CLINICAL PRACTICE
  
  Preparation (16): management (13) and healthcare professional (3)
   Implementation (12): management (7), healthcare professional (4) and patient (1)
     Assessment (10): management (7), healthcare professional (2) and patient (1)
Figure 3. Sequential steps of analysis from the data extraction stage leading to the creation of the final recommendations.
PROM: patient-reported outcome measure.
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Table 4. Recommendations for implementation of PROMs in clinical practice per phases and at different levels.
1. Preparation step
 Management level (13)
-  Initial meeting to explore feasibility of implementation of the measure: planning and evaluating are essential; a coordinator is 
identified to undertake overall responsibility
- Establish clear boundaries at the outset to avoid unrealistic expectations from all actors involved
-  Appraise characteristics and resources of the setting and the requirements of the proposed innovation: that is, it is necessary to 
attune the implementation protocol to the needs of the specific setting and think about good documentation: will allow staff to 
take ownership and understand the benefits of using the chosen measure, which needs to be adaptable to local circumstances
-  Discussions in this step should include assessment of current data collected, how data are collected, what new data items are to 
be extracted, how data can be extracted and provided to who will analyse it, and, which measure(s) to use, especially due to the 
high number of existing measures and the fact that many are used in research or were used in one study only. A measure broadly 
used will allow for comparisons. The aim should be to embed the collection of standardised clinical assessment and other clinically 
relevant data into daily clinical practice with a view to improving clinical care
- Visualisation of results should allow easy and quick interpretation by health-care providers, patients and their families
-  Consider investing in training of clinical key staff: improves data quality and demonstrates that data can be used (a) on a daily 
basis as part of clinical practice and (b) to manage and improve services, that is, data can be used in case conferencing and 
interdisciplinary team meetings and at staff handovers for patient care, discharge planning and discharge and transfer of patients as 
well as audit for quality assurance
- Education and training sessions: consider your setting and organisational needs, when planning, that is, timing of sessions
-  Consider implementation strategies: consistency is paramount. Frequency of use of the measure; burden of completion on patient; 
measures that can be analysed using existing resources; a measure that is easy and quick to use; establish link with a research/audit 
group
-  Consider establishing a program evaluation system for the first month of each phase as well as every 6 months during the first year 
of implementation. Should include feedback from patients, staff members, physicians, nurses (and ITS team if applicable) as well as 
cost savings to the setting
-  Organisational support is needed to maximise the tool’s impact: mechanisms for sharing the information with caregivers need to 
be developed
-  Investment in computerised systems for quick data entry and analysis should be considered. Ways of visualising, storing, retrieving 
and backing up the data should be discussed
- Initiate implementation in stages to improve acceptability
-  Coordinator maintains good relationships with all involved by having both an awareness of the extra time and effort needed to 
implement new outcome measures and providing the appropriate resources and practical support to use the measures and carry 
out data analysis. Cascade management style is adopted
 Health-care professional level (3)
-  Education and training sessions: understanding outcome measurement and why it is important. Administration of chosen measure 
must follow specific guidelines so it is used in a valid way: staff will feel comfortable using it and should obtain adequate patient 
compliance. Standardisation of implementation procedures is critical to the effective use of the measure for quality monitoring but 
it must be balanced with the priority of individualised care
-  Organisational support is needed to maximise the tool’s impact: mechanisms for sharing the information with caregivers need to 
be developed
-  Choosing a measure: efforts should be made to ensure readability and interpretability by patients: reading level, font size and 
general appearance. Should reflect patient situation, quick and easy to use and interpret, validated for population and setting
2. Implementation step
 Management level (7)
-  Maintain strategies of reminders to incorporate the use of the measures in clinical practice, for example, daily assessment easily fits 
with daily routine and does not take additional time, that is, if it is incorporated with moment of control of vital signs: better insight 
into patients’ situation
- Education and motivation of patients could improve compliance
- Timely feedback of results is always done
-  Data that are more time consuming to collect but important for quality reporting are collected periodically, rather than, for 
example, daily
-  Persistence and encouragement by the coordinator are necessary to ensure the implementation is successful and that 
communication among all actors involved is clear
-  Space and time are created to discuss how implementation is going: problems and benefits of using outcome measures are easily 
and rapidly noticeable (what is working and what is not)
-  Coordinator investigates all complaints/issues and addresses them immediately, at the time of the complaint/issue (negative views 
from both patients and professionals tend to be at the outset of implementation when they have not familiarised with the measure)
 Health-care professional level (4)
- Every member of the team who should be using the outcome measures does so
(Continued)
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additional number of factors. The same can be said with 
regard to the different populations in which the included 
studies were conducted. This suggests that the findings 
from this review are applicable to a variety of settings. In 
addition, we originally aimed at identifying facilitators and 
barriers to the implementation of PROMs in clinical prac-
tice in palliative care only. Using the narrative synthesis 
approach allowed us to go further and explore the relation-
ships between the different studies. This led to reorganise 
and synthesise the data in the form of recommendations.
Nevertheless, there are some limitations, starting with 
the quality assessment, which was not an exclusion crite-
rion, and therefore, articles were not excluded even if rated 
as poor quality. Second, there was some discussion between 
reviewers on how to categorise and present these data, 
mainly because some clauses fit more than one theme, and 
repeating those clauses would be more beneficial and accu-
rate. However, the size of the appendices was already sub-
stantial, and there was no information lost by not using 
repetition. Third, the wording in the literature is somewhat 
confusing: the ‘benefits/advantages’ of using PROMs is not 
the same as facilitators of implementation and ‘disadvan-
tages’ of usage of PROMs is not the same as barriers to 
implementation. This is subjective and open to personal 
interpretation. Another potential bias in this review is that 
there was only one reviewer including/excluding articles, 
although a second reviewer would be consulted if there 
were doubts after assessing the full text. Furthermore, only 
one reviewer developed the categories to synthesise the 
data, although a second reviewer appraised those and com-
mented on them. In addition, the grey literature was not 
searched.
Conclusion
Implementing PROMs in palliative care clinical practice 
is an ongoing interactive and continuous process. There is 
a need to identify and address potential barriers to a suc-
cessful implementation of PROMs in clinical practice, 
using appropriate facilitators, tailored to the characteris-
tics of each setting. A key facilitator has to do with the 
role of a coordinator/facilitator throughout the implemen-
tation process. It is important to recognise the ongoing 
cognitive and emotional processes of individuals when 
change is being planned and implemented. The educa-
tional component for health-care professionals prior to the 
implementation is also paramount. This could promote 
ownership and correct use of the measure selected. Ideally, 
this measure should be short and screen for different pal-
liative needs. Online resources and training courses on 
outcome measurement and PROMs for clinicians and 
researchers are starting to emerge.72 Collaborations such 
as the Outcome Assessment and Complexity Collaborative 
(OACC) project are also a step forward in implementing 
PROMs is clinical practice in palliative care.73 In conclu-
sion, there is a need for guidance on implementing 
-  Maintain strategies of reminders to incorporate the use of the measures in clinical practice. Daily assessment easily fits with daily 
routine and does not take additional time
- Interpretation of results is used in practice
- Every member of the team contributes to discussing how implementation is going
 Patient level (1)
- Education and motivation of patients could improve compliance
3. Assessment and improvement (this step will start within the implementation step)
 Management level (7)
- Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect
-  Assess if the measure generated valuable information, without an increase in paperwork, potentially freeing up some time to deliver 
more patient-centred care
-  Assess if practice improved initially as a result of just ‘planting the seed’ of the patient’s needs management. Continue to encourage 
its use, which will improve confidence with the tool
-  Assess if there is a benefit to both patient and practitioner in achieving better outcomes, improved concordance and potentially 
reducing the cost and effort of that management
-  Assess if collation of data generated by the use of the measure allows continuous, accurate collection of information, which should 
reflect the activity of the palliative care team. It should also identify areas of potential future development
- Continue to refine the process to make it more understandable and acceptable to patients and caregivers
- Assess if changes will be made in practice based on the results of implementing and using the measure
 Health-care professional level (2)
- Collected items are reviewed with the aim of being clinically relevant and not burdensome to collect
- Assessing and improving documentation will potentially improve practice and quality of care by highlighting needs
 Patient level (1)
- Assess if there is a benefit to patient in achieving better outcomes
PROM: patient-reported outcome measure.
Table 4. (Continued)
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PROMs in palliative care clinical practice, which could 
potentially improve practice and the quality of care pro-
vided by assisting in clinical decision-making.
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